Header Logo

Connection

LEI NIE to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications LEI NIE has written about Clinical Trials, Phase III as Topic.
LEI NIE
Connection Strength
0.030
Clinical Trials, Phase III as Topic
  1. FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma. Clin Cancer Res. 2017 Nov 15; 23(22):6759-6763.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.